Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania

World Journal of Gastroenterology

Volumn 20, Issue 9, 2014, Pages 2392-2396

  Dumitrescu, Gabriela ^a   Mihai, Catalina ^a   Dranga, Mihaela ^a   Prelipcean, Cristina Cijevschi ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Crohn's disease activity; Inflammatory bowel disease; Northeastern Romania; Seasonality; Vitamin D level

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDY; REMISSION; ROMANIA; SEASONAL VARIATION; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; COLITIS, ULCERATIVE; CROHN DISEASE; RISK FACTOR; SEASON; SEVERITY OF ILLNESS INDEX; TIME;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; INCIDENCE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; ROMANIA; SEASONS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84895877636     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i9.2392     Document Type: Article

References (28)

1. Ardizzone S, Cassinotti A, Trabattoni D, Manzionna G, Rainone V, Bevilacqua M, Massari A, Manes G, Maconi G, Clerici M, Bianchi Porro G. Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol 2009; 22: 63-71 [PMID: 19309553]
2. Wilson J, Hair C, Knight R, Catto-Smith A, Bell S, Kamm M, Desmond P, McNeil J, Connell W. High incidence of inflammatory bowel disease in Australia: a prospective populationbased Australian incidence study. Inflamm Bowel Dis 2010; 16: 1550-1556 [PMID: 20803698 DOI: 10.1002/ibd.21209]
3. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794 [PMID: 21530745 DOI: 10.1053/j.gastro.2011.01.055]
4. Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517 [PMID: 15168363 DOI: 10.1053/j.gastro.2004.01.063]
5. Selmi C. Autoimmunity in 2010. Autoimmun Rev 2011; 10: 725-732 [PMID: 21763468 DOI: 10.1016/j.autrev.2011.06.004]
6. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004; 229: 1136-1142 [PMID: 15564440]
7. Peterlik M, Cross HS. Vitamin D and calcium insufficiencyrelated chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr 2009; 63: 1377-1386 [PMID: 19724293 DOI: 10.1038/ejcn.2009.105]
8. Narula N, Marshall JK. Management of inflammatory bowel disease with vitamin D: beyond bone health. J Crohns Colitis 2012; 6: 397-404 [PMID: 22398052 DOI: 10.1016/ j.crohns.2011.10.015]
9. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753 [PMID: 16698746 DOI: 10.1136/gut.2005.082909]
10. D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007; 132: 763-786 [PMID: 17258735 DOI: 10.1056/NEJM198712243172603,]
11. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444 [PMID: 1248701]
12. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first-and second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol 1999; 94: 2918-2922 [PMID: 10520845 DOI: 10.1111/j.1572-0241.1999.01438.x]
13. Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med 1996; 239: 131-137 [PMID: 8568480 DOI: 10.1046/j.1365-2796.1996.420765000.x]
14. Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol 2003; 17: 473-478 [PMID: 12945007]
15. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 192-199 [PMID: 11843057 DOI: 10.1080/003655 202753416876]
16. Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrügger RW, Brummer RJ. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 2000; 119: 1203-1208 [PMID: 11054377 DOI: 10.1053/ gast.2000.19280]
17. Leslie WD, Miller N, Rogala L, Bernstein CN. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol 2008; 103: 1451-1459 [PMID: 18422819 DOI: 10.1111/ j.1572-0241.2007.01753.x]
18. Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 2006; 12: 1162-1174 [PMID: 17119391 DOI: 10.1097/01.mib.0000236929.74040.b0]
19. Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 2011; 35: 308-316 [PMID: 21527593 DOI: 10.1177/0148607110381267]
20. Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 1985; 26: 1197-1203 [PMID: 3877663 DOI: 10.1136/gut.26.11.1197]
21. Hassan V, Hassan S, Seyed-Javad P, Ahmad K, Asieh H, Maryam S, Farid F, Siavash A. Association between Serum 25 (OH) Vitamin D Concentrations and Inflammatory Bowel Diseases (IBDs) Activity. Med J Malaysia 2013; 68: 34-38 [PMID: 23466764]
22. Tajika M, Matsuura A, Nakamura T, Suzuki T, Sawaki A, Kato T, Hara K, Ookubo K, Yamao K, Kato M, Muto Y. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol 2004; 39: 527-533 [PMID: 15235869 DOI: 10.1007/s00535-003-1338-x]
23. Lamb EJ, Wong T, Smith DJ, Simpson DE, Coakley AJ, Moniz C, Muller AF. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2002; 16: 1895-1902 [PMID: 12390098 DOI: 10.1046/j.1365-2036.2002.01363.x]
24. Andreassen H, Rungby J, Dahlerup JF, Mosekilde L. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 1997; 32: 1247-1255 [PMID: 9438324 DOI: 10.3109/003655297 09028155]
25. Jantchou P, Clavel-Chapelon F, Racine A, Kvaskoff M, Carbonnel F, Boutron-Ruault MC. High residential sun exposure is associated with a low risk of incident Crohn's disease in the prospective E3N cohort. Inflamm Bowel Dis 2014; 20: 75-81 [PMID: 24247650]
26. Joseph AJ, George B, Pulimood AB, Seshadri MS, Chacko A. 25 (OH) vitamin D level in Crohn's disease: association with sun exposure disease activity. Indian J Med Res 2009; 130: 133-137 [PMID: 19797809]
27. McCarthy D, Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther 2005; 21: 1073-1083 [PMID: 15854168 DOI: 10.1111/j.1365-2036.2005.02446.x]
28. Blanck S, Aberra F. Vitamin d deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci 2013; 58: 1698-1702 [PMID: 23334382 DOI: 10.1007/s10620-012-2531-7]